Catamaran Bio
Cristina Panaroni, Ph.D. is a Principal Scientist at Catamaran Bio, with extensive experience in translational research on Multiple Myeloma. Previous roles include Senior Scientist at Ensoma and various research positions at prestigious institutions such as Harvard Medical School and Stanford University. Panaroni's expertise lies in the role of bone marrow microenvironment and mesenchymal stem cells in MM onset and propagation. A dedicated professional with a strong background in biology and biotechnology.
Catamaran Bio
Catamaran Bio is a newly-formed biotechnology company funded by SV Health Investors. Catamaran is developing transformative off-the-shelf CAR-NK cell therapies.